American expands preflight testing to all U.S. destinations with travel restrictions
Reuters
Published Dec 08, 2020 08:58AM ET
(Reuters) - American Airlines (NASDAQ:AAL) said on Tuesday it is expanding preflight COVID-19 testing for all U.S. destinations that have travel restrictions.
The test, priced at $129 which includes a medical professional virtually assisting and express shipping both ways, will be available for purchase for passengers traveling on or after Dec. 12.
In collaboration with at-home testing partner LetsGetChecked, American said it will provide testing for travel to cities, states and territories currently under COVID-19 travel restrictions, including Puerto Rico.
In November, the airline had expanded its at-home testing to new destinations in the Caribbean, Latin America and Hawaii.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.